» Guest Researchers

photo of Hanieh Ariani
Hanieh Ariani
Postdoctoral Fellow
Rinker Health Science Campus
(714) 516-5461
Hanieh joined Chapman University School of Pharmacy as a postdoctoral fellow in the lab of Prof. Kaur in March 2016. She graduated from Polish Academy of Sciences, Institute of Biophysics and Biochemistry (IBB). She worked on synthetic peptides hydrolysable by toxic metals.
She is a biochemist that uses chemical synthesis to produce bioactive peptides. Along with chemical synthesis she did structural studies of peptides alone or with metal complexes. Moreover she is interested in in-vivo studies.
She has an experience in synthesizing antibacterial peptides and their characterization. She had opportunity to work with various fields of basic sciences ranging from biology to chemistry as she got her major in biology and moved to biophysics and biochemistry fields in master and PhD.
Her current study focuses on engineering peptides for therapeutic purposes.
photo of Chunmei Cheng
Chunmei Cheng
Senior Research Associate
Rinker Health Science Campus
(714) 516-5443
Research Interests The immunotherapy is extremely attractive to clinic physicians as well as to the patients who are suffering from incurable cancers and autoimmune diseases due to its specific targeting and less side affects. The pathogenesis and immunogenesis are the fundamental accesses to address the targets for the specific immunotherapy. My research interests are the pathogenesis and immunogenesis of various cancers and autoimmune related diseases, and the design and development of immunotherapeutics for those resistant to the conventional treatments. Both in vitro and in vivo models are the substantial approaches in my studies
photo of Barent DuBois
Barent DuBois
Postdoctoral Fellow
Rinker Health Science Campus
(714) 516-5453
Dr. Barent DuBois joined the Chapman University School of Pharmacy as a Postdoctoral Fellow in July 2015 after submitting his PhD dissertation in pharmaceutical sciences at Oregon State University, where he worked at the OSU College of Pharmacy campus at Oregon Health & Science University in Portland, Oregon. He has been studying how the maternal and intrauterine environment affects fetal development, altering the anatomical, physiological and epigenetic substrate on which an individual’s pharmacokinetic (PK) phenotype is expressed throughout the lifespan.
Dr. DuBois is a pharmacokineticist with a background in clinical and translational medical research, utilizing animal and human models of obesity, intrauterine growth restriction, and pregnancy. His graduate training involved bioanalysis with HPLC and tandem mass spectrometry, in vitro assays for drug metabolism and drug transport, and pharmacokinetic analysis utilizing non-compartmental, modeling and simulation, non-linear mixed effects. He is interested in how physiological and mechanism based models of pharmacokinetics can be used to identify the degree of risk and mechanisms for adverse drug events in disease, particularly non-communicable chronic diseases.
Currently Dr. DuBois works with Dr. Reza Mehvar studying blood-brain barrier permeability in cirrhosis and acute liver failure, and how liver diseases alter pharmacokinetics.
photo of Shilpi Gupta
Shilpi Gupta
Affiliated Scholar
(714) 516-5449
Dr. Shilpi Gupta is currently a Fulbright Scholar at the Chapman School of Pharmacy under the prestigious SERB Indo-US Postdoctoral Research Grant from India. She has worked as an Assistant Professor in the Department of Chemistry, Hindu College, Sonipat, India since Oct, 2013. In 2011 she joined the research group of Prof. Rainer Haag at the Freie Universitat Berlin, Germany for her Postdoctoral work where she pursued her research in the field of design and development of amphiphilic polymers, polymer-drug conjugates for the passive targeted delivery of drugs.
She received her Ph.D. in Organic Chemistry in 2011 from the University of Delhi, India, under the supervision of Prof. Sunil K. Sharma. Her research work included design and synthesis of Benzopyrones, Guanidinylated Peptide Nucleic Acid Building Blocks, and Chemoenzymatic Synthesis of Glycerol-Based Polymeric and Dendritic Architectures. Her current interests at Chapman University School of Pharmacy are in the design and development of potent heterocyclic compounds as Protein Tyrosine Kinase inhibitors.
photo of Rukhsana Lalani, Ph.D.
Rukhsana Lalani, Ph.D.
Affiliated Scholar
(626) 222-9462
Dr. Lalani joined the Chapman University, School of Pharmacy in August 2015 with Dr. Aftab Ahmed’s research group. She received her B.Sc. (Hons) in Chemistry and M.Sc. in Physical Chemistry from University of Karachi in 1977. Later, she joined a MS program at Western Carolina University, NC, USA in 1978. She received her Ph.D. in Protein Chemistry at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan in 1985.
After the graduation, she joined the Clinical Laboratories at the Aga Khan University Hospital, Karachi, Pakistan, where she established and implemented the Quality Systems. She joined the department of Endocrinology at Charles Drew University as Sr. Research Associate in 1997, where she worked in research projects on Microgravity and Aging processes, and its relation to Myostatin gene, which resulted in several publications in the reputable scientific Journals.
Later, she joined Baxter BioScience, a plasma product manufacturing company at the very inception of their state of the art automated plasma fractionating facility. During her time at Baxter, as project manager, she was the key contributor for the development and transfer of the plasma fractionation process from manual to the automated facility. She also participated in their Internal, External third party Pre-Audit Inspections (PAI) and Regulatory Agencies Audits. She was with Baxter till the automated manufacturing process was approved by FDA.. After leaving Baxter in July 2010, she continued consulting to the medical device and pharmaceutical industries. She also worked as adjunct faculty at American University of Health Sciences (AUHS), teaching for the MSCR program. Currently, she is consulting at LabDX Inc.
Dr. Lalani’s current research interest at Chapman University, School of Pharmacy, includes proteomic profiling, protein purification, characterization, including amino acid sequencing and mass spectrometry techniques. She is working on bioactive proteins and peptides from various species of plants used in folk medicines in various parts of the world. From her research, Dr. Lalani has authored or co-authored 12 peer reviewed publications.
photo of Young Woo Nam, Ph.D.
Young Woo Nam, Ph.D.
Postdoctoral Fellow
(714) 516-5495
Dr. Young Woo Nam joined the Chapman University School of Pharmacy as a Postdoctoral Fellow in November 2015. He received his Ph.D. in Department of Biotechnology at University of Tokyo, Japan. He studied three-dimensional structures of Glycoside Hydrolases (GHs) for understanding cellular metabolisms and determined two novel crystal structures. One of his work was published in Journal of Biological Chemistry (2015).
Dr. Nam is a structural biologist specializing in blending computational and experimental approaches to elucidate the molecular structure of proteins utilizing X-ray diffraction, computational biology image processing, bioinformatics and structural prediction. He is interested in protein conformational changes, protein-ligand interactions and structure-based drug design of small-conductance K+ channels (SK channels). Currently Dr. Nam researches with Dr. Zhang on the pharmacological modulation of KCa2/3 channels by small molecule drugs and structure based drug discovery for SK channels.
photo of Pala Rajasekharreddy, Ph.D.
Pala Rajasekharreddy, Ph.D.
Postdoctoral Fellow
Rinker Health Science Campus
(714) 516-5462
Dr. Pala Rajasekharreddy joined Chapman University School of Pharmacy in February 2015 as a Post-Doctoral researcher. He earned his PhD in Biological Sciences from Academy of Scientific and Innovative Research (AcSIR), New Delhi.
Dr. Pala is a Nano biotechnologist specialized in the Biological/Green synthesis of various metal and metal oxide nanoparticles with their application as drug delivery agents. After his post-graduation he was selected for ICMR-Research Fellowship under Biomedical Sciences in 2011 and during this period of his doctoral studies at CSIR-Indian Institute of Chemical Technology, India, he has earned handsome experience on the physical and chemical characterizations techniques of nanoparticles that are enveloped with various biologically active compounds such as protein, lipids and small molecular drugs for their biomedical applications.
Dr. Pala is a Nano biotechnologist specialized in the Biological/Green synthesis of various metal and metal oxide nanoparticles with their application as drug delivery agents. After his post-graduation he was selected for ICMR-Research Fellowship under Biomedical Sciences in 2011 and during this period of his doctoral studies at CSIR-Indian Institute of Chemical Technology, India, he has earned handsome experience on the physical and chemical characterizations techniques of nanoparticles that are enveloped with various biologically active compounds such as protein, lipids and small molecular drugs for their biomedical applications.
Current Research: Understanding primary cilia and their associated diseases by using different nanoparticles mediated therapeutic agents.
photo of Victoria  Wu
Victoria Wu
Research Scientist
(714) 516-5430
Victoria Wu, PhD, joined the Department of Biomedical and Pharmaceutical Sciences at Chapman University School of Pharmacy (CUSP) as a senior research associate in October 2016. Dr. Wu earned a PhD degree in Molecular and Cellular Biology from Northwestern University, where she conducted research centered on characterizing genes involved in Drosophila tracheal development. From 2006 to 2011 she was a postdoctoral researcher in the Department of Biochemistry at the University of California in San Francisco, pursuing research on mammalian embryogenesis and novel drug inhibitors of Hedgehog signal transduction.
Prior to her joining CUSP, Dr. Wu was also a staff scientist in the Department of Bioengineering at Stanford University, where she did research on the mechanical forces involved in zebrafish embryogenesis and on remote science experiments for K-12 students; an adjunct faculty member in the Department of Biology at San Jose City College, where she taught a lab and a lecture course in General Microbiology; and a visiting research assistant professor in the Department of Bioengineering at the University of Illinois in Chicago, where she studied the biological effects of nanoparticle interaction with cellular systems relevant for infectious disease and cancer.
Dr. Wu is the recipient of the 2006 NIH Institutional Research Service Award in Molecular and Cellular Basis of Cardiovascular Disease. Her research accomplishments have been paralleled by her passion for teaching: Dr. Wu was a course coordinator at Northwestern University and also taught cell biology, microbiology, genetics and osteology at various levels, ranging from the Miraloma Elementary School in San Francisco to K-12 students in the UCSF Center for Science & Education Opportunity program to departments of biology and anthropology at San Jose State University to, most recently, schools of engineering and medicine at the University of Illinois at Chicago.